KRAS(G12C)-independent feedback activation of wild-type RAS constrains KRAS(G12C) inhibitor efficacy

Although KRAS has long been considered undruggable, direct KRAS(G12C) inhibitors have shown promising initial clinical efficacy. However, the majority of patients still fail to respond. Adaptive feedback reactivation of RAS-mitogen-activated protein kinase (MAPK) signaling has been proposed by our g...

Descripción completa

Detalles Bibliográficos
Autores principales: Ryan, Meagan B., Coker, Oluwadara, Sorokin, Alexey, Fella, Katerina, Barnes, Haley, Wong, Edmond, Kanikarla, Preeti, Gao, Fengqin, Zhang, Youyan, Zhou, Lian, Kopetz, Scott, Corcoran, Ryan B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809542/
https://www.ncbi.nlm.nih.gov/pubmed/35732135
http://dx.doi.org/10.1016/j.celrep.2022.110993

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809542/
https://www.ncbi.nlm.nih.gov/pubmed/35732135
http://dx.doi.org/10.1016/j.celrep.2022.110993

Ejemplares similares